tenk.fyi

Maze Therapeutics, Inc.

MAZENasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$131.1M

351.0% YoY

EPS

$-3.05

344.0% YoY

Cash

$189.2M

3.8% YoY

FY 2025 · As of 2025-12-31